Tech Company Financing Transactions
ViroCyt Funding Round
ViroCyt, based in Broomfield, received $3.5 million from private investors.
Transaction Overview
Company Name
Announced On
1/15/2015
Transaction Type
Venture Equity
Amount
$3,467,888
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Technology Dr. 325
Broomfield, CO 80021
USA
Broomfield, CO 80021
USA
Phone
Website
Email Address
Not Recorded
Overview
ViroCyt's primary objective is bringing high value solutions to the life science industry that address critical unmet needs. Our first product is the Virus Counter, a revolutionary instrument that allows enumeration of intact viral particles in minutes instead of days or weeks.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Technical Officer
Michael Olszowy
VP - Marketing
Michael Artinger
VP - Sales
Greg Krueger
Browse more venture capital transactions:
Prev: 1/15/2015: Driftt venture capital transaction
Next: 1/15/2015: mdBriefCase venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs